Phase I Clinical Trial

Phase I clinical trials are conducted to test a new drug candidate in a small group of subjects to evaluate safety and tolerability and to determine blood levels of the drug. PBT434 is preparing to enter the clinic in a Phase 1 clinical trial in mid-2018 in healthy volunteers.